Article ID Journal Published Year Pages File Type
3282151 Clinical Gastroenterology and Hepatology 2013 8 Pages PDF
Abstract
Although a significantly higher percentage of patients who continue thienopyridine therapy during colonoscopy and polypectomy develop clinically important delayed PPB than patients who discontinue therapy, the rate of PPB events is low (2.4%), and all are resolved without sequelae. The risk for catastrophic cardiovascular risks among patients who discontinue thienopyridine therapy before elective colonoscopies could therefore exceed the risks of PPB. ClinicalTrials.gov, Number NCT01647568.
Related Topics
Health Sciences Medicine and Dentistry Gastroenterology
Authors
, , , , , , , ,